Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5023,810.851.58%H 23,810.85 · L 23,482.8upd. 03 Nov, 3:31 PM IST|Sensex76,917.851.62%H 76,917.85 · L 76,033.74upd. 03 Nov, 3:32 PM IST|Bank Nifty55,540.050.98%H 55,739 · L 55,174.1upd. 03 Nov, 3:31 PM IST|USD / INR₹94.730.17%H ₹94.89 · L ₹94.6as of 2:21 AM IST|Gold Intl (10g)₹1,19,906.770.09%H ₹1,20,235.7 · L ₹1,19,861.08as of 5:14 AM IST|Silver Intl (1kg)₹1,51,337.750.13%H ₹1,52,190.53 · L ₹1,51,307.29as of 5:14 AM IST|Crude WTI₹9,124.390.24%H ₹9,171.76 · L ₹9,077.03as of 5:14 AM IST|Bitcoin₹73,65,5881.35%H ₹74,15,155.36 · L ₹73,16,020.64as of 5:14 AM IST|Ethereum₹2,16,3641.52%H ₹2,18,003.6 · L ₹2,14,724.4as of 5:14 AM IST|Nifty 5023,810.851.58%H 23,810.85 · L 23,482.8upd. 03 Nov, 3:31 PM IST|Sensex76,917.851.62%H 76,917.85 · L 76,033.74upd. 03 Nov, 3:32 PM IST|Bank Nifty55,540.050.98%H 55,739 · L 55,174.1upd. 03 Nov, 3:31 PM IST|USD / INR₹94.730.17%H ₹94.89 · L ₹94.6as of 2:21 AM IST|Gold Intl (10g)₹1,19,906.770.09%H ₹1,20,235.7 · L ₹1,19,861.08as of 5:14 AM IST|Silver Intl (1kg)₹1,51,337.750.13%H ₹1,52,190.53 · L ₹1,51,307.29as of 5:14 AM IST|Crude WTI₹9,124.390.24%H ₹9,171.76 · L ₹9,077.03as of 5:14 AM IST|Bitcoin₹73,65,5881.35%H ₹74,15,155.36 · L ₹73,16,020.64as of 5:14 AM IST|Ethereum₹2,16,3641.52%H ₹2,18,003.6 · L ₹2,14,724.4as of 5:14 AM IST|
0%
Stock MarketBreaking

Molbio Diagnostics IPO Subscribed 17.37 Times on Day 3; GMP at ₹138

Arth Vani DeskPublished: 1 min read
Molbio Diagnostics IPO Subscribed 17.37 Times on Day 3; GMP at ₹138

Source: Mint Markets

Arth Insight · What this means for your wallet

Immediate action
If you applied for the Molbio Diagnostics IPO, check your allotment status.
  • If you are allotted shares, you could see a quick profit (listing gain) once the shares are listed, indicated by the Grey Market Premium (GMP) of ₹138.
  • If you applied but are not allotted shares, your application money will be unblocked and returned to your bank account.
  • For future IPOs, strong oversubscription and high GMP show market interest, but they don't guarantee profits. Always research the company's financials thoroughly before investing your hard-earned money.
Recommended for you
Track live indices, stocks & movers
Open Markets
Listen to this article
AI voice · Podcast mode
Get IPO & market alerts free on Telegram / WhatsApp
AI Summary

The Molbio Diagnostics IPO has seen strong investor interest, being subscribed 17.37 times by the end of Day 3. The grey market premium (GMP) for the shares is currently ₹138, indicating potential listing gains.

Key Highlights
  • ▸Molbio Diagnostics IPO was subscribed 17.37 times by Day 3.
  • ▸The grey market premium (GMP) for Molbio Diagnostics shares is ₹138.
  • ▸High subscription and GMP suggest strong investor interest, but are not guarantees of listing performance.
Key Takeaways
  • ✓Molbio Diagnostics IPO was subscribed 17.37 times by Day 3.
  • ✓The grey market premium (GMP) for Molbio Diagnostics shares is ₹138.
  • ✓High subscription and GMP suggest strong investor interest, but are not guarantees of listing performance.

The initial public offering (IPO) of Molbio Diagnostics has garnered significant attention from investors, with the issue being subscribed 17.37 times by the close of the third day of bidding. This strong demand is further reflected in the grey market, where the shares are trading at a premium.

Grey Market Premium (GMP) Details

The grey market premium (GMP) for Molbio Diagnostics shares currently stands at approximately ₹138 per share. The GMP is an unofficial indicator of investor sentiment and the potential listing price of an IPO, reflecting the premium at which shares are traded in the grey market before their official listing on stock exchanges.

What This Means for Retail Investors

A high subscription rate and a positive GMP often suggest strong investor confidence in the company's prospects and the potential for listing gains. However, it is crucial for retail investors to remember that GMP is not a guaranteed indicator of future performance or listing price. The actual listing price can be influenced by various market factors on the day of listing.

Investors who have applied for the Molbio Diagnostics IPO will now await the allotment process. Those considering future IPOs should always conduct thorough research into the company's fundamentals, financial health, and industry outlook, rather than solely relying on grey market premiums.

This article is for informational purposes only and does not constitute financial or investment advice.

Recommended for you
Products related to this story — compare & act
Smart picks
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
12.9%
3Y CAGR
Bharat Mobility IPO
Mainboard · Auto
+20.5%
GMP
View IPO
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
12.2%
3Y CAGR
GreenVolt Energy IPO
Mainboard · Renewables
+13.8%
GMP
View IPO
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
12.1%
3Y CAGR
Axis ELSS- Tax Saver Fund
Axis Mutual Fund · ELSS
10.8%
3Y CAGR

Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.

Frequently Asked Questions

What does 'subscribed 17.37 times' mean for an IPO?

It means that investors have bid for 17.37 times more shares than the total number of shares offered in the IPO, indicating very high demand.

What is Grey Market Premium (GMP) in an IPO?

GMP is the unofficial premium at which an IPO's shares trade in the grey market before their official listing. It reflects market sentiment and potential listing gains, but is not a guarantee.

Should I rely on GMP when deciding to invest in an IPO?

While GMP can indicate market sentiment, it is an unofficial figure and should not be the sole basis for your investment decision. Always research the company's financials and future prospects.

Stay ahead of the market

Join the Arth Vani channels

Daily news summaries, IPO & market alerts on Telegram and WhatsApp.

Related Stories

US Treasury Yields Slide as Dropping Oil Prices Ease Fed Rate Hike Fears
Stock Market

US Treasury Yields Slide as Dropping Oil Prices Ease Fed Rate Hike Fears

US Treasury yields have seen their biggest monthly advance in over two years, extending a recent slide. This movement is primarily driven by falling global oil prices, which are easing concerns about inflation and reducing the likelihood of additional interest rate hikes by the US Federal Reserve.

1d ago·1 min readListen
Nasdaq 100 Enters Correction Amid Growing Concerns Over Big Tech and AI
Stock Market

Nasdaq 100 Enters Correction Amid Growing Concerns Over Big Tech and AI

The Nasdaq 100 Index, a key benchmark for major technology companies, officially entered a market correction on Monday. This decline signals increasing investor apprehension regarding the valuations of Big Tech firms and the long-term prospects of the artificial intelligence (AI) sector.

1d ago·2 min readListen
China Boosts Stock Market Stability with Enhanced Support Tools
Stock Market

China Boosts Stock Market Stability with Enhanced Support Tools

China is encouraging its financial institutions to make fuller use of two designated stock support tools, alongside optimizing their existing terms. This strategic move aims to bolster market stability and restore investor confidence within the world's second-largest economy.

1d ago·1 min readListen
Sensex Jumps 630 Points, Nifty Reclaims 16,500 Amid Positive Global Cues
Stock Market

Sensex Jumps 630 Points, Nifty Reclaims 16,500 Amid Positive Global Cues

The Indian stock market witnessed significant gains in a recent trading session, with the Sensex surging 630 points and the Nifty 50 reclaiming the crucial 16,500 level. This upward movement was primarily driven by positive sentiment stemming from firm global market trends, signaling broad investor confidence.

1d ago·2 min readListen